Arca
Skip to content
Tools
Tools

Peripheral arterial disease

Drug research and approvals for peripheral arterial disease: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 228 studies of peripheral arterial disease are recruiting on ClinicalTrials.gov, Health Canada has authorized 0 drug trials for it since 2013, and FDA has 0 approved and 2 open orphan designations naming it.

  • Recruiting worldwide: 228
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting now

Newest posted first, of 228 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Approved 3

Phase 3 12 of 16

Phase 2 12 of 22

Phase 1 or earlier 10

How its trials ended

1,466 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 330 whose ending is known, 47% met their primary endpoint, 8% missed it and 45% stopped early.

  • Completed, result not reported57539%
  • Ongoing30521%
  • Status unknown25617%
  • Met its primary endpoint15411%
  • Stopped: other or unclear816%
  • Stopped: enrollment or feasibility312%
  • Missed its primary endpoint272%
  • Stopped: sponsor or business decision191%
  • Stopped: lack of efficacy101%
  • Stopped: funding81%

FDA orphan designations

Approved first, then open designations, newest first
Feb 8, 2021Hexasodium salt of myo-inositol hexaphosphate (IP6,…Treatment of peripheral arterial disease in patients with end-stage kidney diseaseVifor Pharma, Inc.Designated
Sep 10, 1996Prostaglandin E1 in lipid emulsionTreatment of ischemic ulceration of the lower limbs due to peripheral arterial disease.Alpha Therapeutic CorporationDesignated

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.